Transfusional Iron Overload in β-thalassemia
1 clinical trials · Condition
◉ Watch Transfusional Iron Overload in β-thalassemia
| Record | Firm | Date |
|---|---|---|
| An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload (NCT00171210) | Novartis Pharmaceuticals | 2004-10-01 |
Track Transfusional Iron Overload in β-thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.